Ole Joergen Kaasboell

Ole Joergen Kaasboell is currently serving as the Chief Scientific Officer at Tribune Therapeutics since April 2021. Prior to this role, was a Postdoc at Oslo University Hospital (RH)/University of Oslo from 2019 to April 2021, where previously Ole Joergen had worked as an MD PhD student and a stipendiat. Ole Joergen also has experience as a General Practitioner at a general practice and as a Physician at Førde Sentralsjukehus. Ole Joergen Kaasboell holds a PhD in Biochemistry and Molecular Biology from the University of Oslo, along with various other degrees in health innovation, statistics, health economics, medicine, and obstetrics/gynecology & pediatrics.